Baum's Textbook of Pulmonary Diseases. (Record no. 93315)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 11193nam a22005293i 4500 |
001 - CONTROL NUMBER | |
control field | EBC3418680 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | MiAaPQ |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20240729125701.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
fixed length control field | m o d | |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | cr cnu|||||||| |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 240724s2003 xx o ||||0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9781469875675 |
Qualifying information | (electronic bk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
Canceled/invalid ISBN | 9780781737272 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (MiAaPQ)EBC3418680 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (Au-PeEL)EBL3418680 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (CaPaEBR)ebr10865240 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (CaONFJC)MIL72863 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (OCoLC)880453940 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | MiAaPQ |
Language of cataloging | eng |
Description conventions | rda |
-- | pn |
Transcribing agency | MiAaPQ |
Modifying agency | MiAaPQ |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
Classification number | RC756 -- .B386 2004eb |
082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 616.2/4 |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Crapo, James D. |
245 10 - TITLE STATEMENT | |
Title | Baum's Textbook of Pulmonary Diseases. |
250 ## - EDITION STATEMENT | |
Edition statement | 7th ed. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Place of production, publication, distribution, manufacture | Philadelphia : |
Name of producer, publisher, distributor, manufacturer | Lippincott Williams & Wilkins, |
Date of production, publication, distribution, manufacture, or copyright notice | 2003. |
264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | ©2004. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1 online resource (1518 pages) |
336 ## - CONTENT TYPE | |
Content type term | text |
Content type code | txt |
Source | rdacontent |
337 ## - MEDIA TYPE | |
Media type term | computer |
Media type code | c |
Source | rdamedia |
338 ## - CARRIER TYPE | |
Carrier type term | online resource |
Carrier type code | cr |
Source | rdacarrier |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Cover -- Copyright -- DEDICATION -- EDITORS -- PREFACE -- PREFACE TO THE FIRST EDITION -- FOREWORD -- ACKNOWLEDGMENTS -- Contents -- Section I Diagnostic Methods -- Chapter 1 Imaging of Lung Disease -- CHEST RADIOGRAPHIC TECHNIQUES -- COMPUTED TOMOGRAPHY TECHNIQUES -- NUCLEAR MEDICINE TECHNIQUES -- LUNG MAGNETIC RESONANCE IMAGING -- ULTRASOUND -- INTERVENTIONAL THORACIC RADIOLOGY -- RADIOLOGIC ANATOMY -- APPROACH TO CHEST RADIOGRAPHS -- RADIOLOGIC SIGNS OF LUNG DISEASE -- ABNORMALITIES OF THE SECONDARY PULMONARY LOBULE -- SPECIFIC IMAGING ISSUES IN EVALUATION OF LUNG DISEASE -- SUMMARY -- Chapter 2 Pulmonary Function Testing -- STATIC LUNG VOLUMES -- DYNAMIC TESTS OF LUNG FUNCTION -- DIFFUSION -- RESPIRATORY MUSCLE STRENGTH -- TESTS OF ELASTIC PROPERTIES -- ARTERIAL BLOOD GASES -- REFERENCES VALUES -- GENERAL INTERPRETATIVE GUIDELINES -- SUMMARY -- Chapter 3 Clinical Exercise Testing -- CLINICAL EXERCISE TESTING -- MEASUREMENTS -- CLINICAL SIGNS AND SYMPTOMS -- BREATHING PATTERN AND STRATEGY -- EXERCISE LIMITATION -- INTERPRETATION -- SUMMARY/INTERPRETATION -- ACKNOWLEDGMENTS -- Chapter 4 Bronchoscopy -- BRONCHOSCOPIC TECHNIQUES -- CANCER DIAGNOSIS -- DIFFUSE PARENCHYMAL LUNG DISEASE IN IMMUNOCOMPETENT PATIENTS -- INFECTIOUS DISEASES -- HEMOPTYSIS -- THERAPEUTIC APPLICATIONS -- Chapter 5 Invasive Pulmonary Diagnostic Procedures: Pleural Diagnostic Procedures -- THORACENTESIS -- PLEURAL BIOPSY AND ENDOSCOPY TECHNIQUES -- THORACOSCOPY (PLEUROSCOPY) -- OPEN (SURGICAL) PLEURAL BIOPSY -- Chapter 6 Preoperative Evaluation and Relation to Postoperative Complications -- MAJOR POSTOPERATIVE PULMONARY COMPLICATIONS -- OTHER RISK FACTORS -- PREOPERATIVE EVALUATION OF PATIENTS NOT UNDERGOING LUNG RESECTION -- PREOPERATIVE EVALUATION OF PATIENTS UNDERGOING LUNG RESECTION -- REDUCTION IN COMPLICATIONS -- Section II Obstructive Lung Disease. |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Chapter 7 Pulmonary Aerosols -- INTRODUCTION -- AEROSOLS AND THE MECHANICS OF AIRFLOW AND PARTICLE DISTRIBUTION IN THE AIRWAYS -- AEROSOL DELIVERY DEVICES -- Chapter 8 The Epidemiology of Asthma -- INTRODUCTION -- NATURAL HISTORY -- PREVALENCE, INCIDENCE, MORBIDITY, AND MORTALITY: THE ASTHMA EPIDEMIC -- EMERGING RISK FACTORS TO EXPLAIN THE INCREASE IN ASTHMA -- DIET -- OBESITY -- HYGIENE HYPOTHESIS (INFECTION) -- STRESS -- SUMMARY -- Chapter 9 Pathophysiology of Asthma -- INFLAMMATION -- INFLAMMATORY CELLS -- INFLAMMATORY MEDIATORS -- EFFECTS OF INFLAMMATION -- TRANSCRIPTION FACTORS -- ANTIINFLAMMATORY MECHANISMS -- Chapter 10 Diagnosis and Treatment of Asthma -- MAKING THE DIAGNOSIS OF ASTHMA -- CLINICAL PHENOTYPES OF ASTHMA -- SPECIAL CLINICAL SITUATIONS IN ASTHMA -- EVALUATION AND TREATMENT OF COMORBID CONDITIONS -- INDIVIDUAL PHARMACOLOGIC AGENTS IN THE TREATMENT OF ASTHMA -- COMBINATION THERAPY FOR ASTHMA -- CONSENSUS GUIDELINES AND THE MANAGEMENT OF ASTHMA -- PEAK FLOW MONITORING, SELF-MANAGEMENT, AND THE ASTHMA ACTION PLAN -- INTEGRATED APPROACH TO ASTHMA MANAGEMENT -- Chapter 11 Epidemiology of Chronic Obstructive Pulmonary Disease -- DEFINITIONS -- MORTALITY -- PREVALENCE -- SMOKING AND THE NATURAL HISTORY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE -- RISK FACTORS -- Chapter 12 COPD: Clinical Manifestations, Diagnosis, and Treatment -- EPIDEMIOLOGY -- RISK FACTORS FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE -- PATHOPHYSIOLOGY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE -- DIAGNOSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE -- MANAGEMENT OF STABLE CHRONIC OBSTRUCTIVE PULMONARY DISEASE -- MAINTENANCE THERAPIES -- MANAGEMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE -- α1-ANTITRYPSIN DEFICIENCY -- SURGICAL THERAPY FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE -- Chapter 13 Cystic Fibrosis -- EPIDEMIOLOGY -- PATHOGENESIS. |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | CLINICAL FEATURES -- DIAGNOSIS -- MANAGEMENT -- SUMMARY -- Chapter 14 Bronchiectasis -- PATHOLOGY AND PATHOPHYSIOLOGY -- CLINICAL FEATURES -- SPECIFIC CAUSES OF BRONCHIECTASIS -- SYSTEMIC DISEASE -- TREATMENT -- COMPLICATIONS AND PROGNOSIS -- Chapter 15 Smoking Cessation -- MODEL OF CHRONIC DISEASE -- CLINICAL INTERVENTION -- PHARMACOTHERAPY -- COUNSELING -- SUMMARY -- Chapter 16 Pulmonary Rehabilitation -- DEFINITION AND CONCEPT OF PULMONARY REHABILITATION -- KEY COMPONENTS OF COMPREHENSIVE PULMONARY REHABILITATION -- MEDICAL EVALUATION AND MANAGEMENT -- INITIAL ASSESSMENT -- THERAPEUTIC INTERVENTIONS -- LONG-TERM PROGRAM -- POTENTIAL OUTCOMES OF PULMONARY REHABILITATION -- TOOLS FOR ASSESSING QUALITY-OF-LIFE OUTCOMES -- OUTCOMES OF PULMONARY REHABILITATION -- ACKNOWLEDGMENT -- Section III Infectious Diseases -- Chapter 17 Upper Respiratory Tract Infections -- INFECTIONS OF THE ORAL CAVITY -- RHINITIS -- SINUSITIS -- PHARYNGITIS -- EPIGLOTTITIS -- LARYNGOTRACHEOBRONCHITIS -- ACUTE BRONCHITIS (OR TRACHEOBRONCHITIS) -- BRONCHIOLITIS -- Chapter 18 Pulmonary Infections in the Immunocompromised Host -- APPROACH TO THE IMMUNOCOMPROMISED HOST WITH SUSPECTED PULMONARY INFECTION -- DIAGNOSTIC PROCEDURES -- EMPIRIC THERAPY -- SPECIFIC PATHOGENS -- Chapter 19 Pulmonary Fungal Infections -- HISTOPLASMOSIS -- BLASTOMYCOSIS -- COCCIDIOIDOMYCOSIS -- CRYPTOCOCCOSIS -- ASPERGILLOSIS -- ACTINOMYCOSIS AND NOCARDIOSIS -- Chapter 20 Pulmonary Infections Caused by Mycobacterial Species -- DISEASE CAUSED BY MYCOBACTERIUM TUBERCULOSIS -- DISEASE CAUSED BY NONTUBERCULOUS MYCOBACTERIA -- Chapter 21 Anaerobic and Other Infection Syndromes -- ASPIRATION PNEUMONIA -- LUNG ABSCESS -- LIPOID PNEUMONIA -- ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE -- Chapter 22 Pneumonia, Including Community-Acquired and Nosocomial Pneumonia -- PATHOGENESIS. |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | COMMUNITY-ACQUIRED PNEUMONIA -- NOSOCOMIAL PNEUMONIA -- EDITOR's NOTE: SEVERE ACUTE RESPIRATORY SYNDROME -- Section IV Inflammatory and Interstitial Diseases -- Chapter 23 Approach to the Patient with Interstitial Lung Disease -- INCIDENCE AND PREVALENCE -- CLINICAL ASSESSMENT OF PATIENTS WITH INTERSTITIAL LUNG DISEASE -- MANAGEMENT OF INTERSTITIAL LUNG DISEASES -- Chapter 24 Idiopathic Interstitial Pneumonias -- NEW AMERICAN THORACIC SOCIETY/EUROPEAN RESPIRATORY SOCIETY MULTIDISCIPLINARY CLASSIFICATION OF IDIOPATHIC INTERSTITIAL PNEUMONIAS -- GENERAL CONSIDERATIONS IN THE DIAGNOSIS OF IDIOPATHIC INTERSITIAL PNEUMONIAS -- IDIOPATHIC PULMONARY FIBROSIS -- NONSPECIFIC INTERSTITIAL PNEUMONIA -- CRYPTOGENIC ORGANIZING PNEUMONIA -- ACUTE INTERSTITIAL PNEUMONIA -- RESPIRATORY BRONCHIOLITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE AND DESQUAMATIVE INTERSTITIAL PNEUMONIA -- LYMPHOCYTIC INTERSTITIAL PNEUMONIA -- OTHER ISSUES IN GENERAL MANAGEMENT -- ACKNOWLEDGMENT -- Chapter 25 Hypersensitivity Pneumonitis -- EPIDEMIOLOGY -- CLINICAL PRESENTATION -- CHEST IMAGING STUDIES -- PATHOLOGY -- LABORATORY FINDINGS -- PULMONARY FUNCTION TESTS -- DIFFERENTIAL DIAGNOSIS -- DIAGNOSIS -- PATHOGENESIS -- PROGNOSIS AND TREATMENT -- CONCLUSION -- Chapter 26 Connective Tissue Diseases -- INTERSTITIAL PNEUMONIA IN RHEUMATIC DISORDERS -- RHEUMATOID ARTHRITIS -- SYSTEMIC LUPUS ERYTHEMATOSUS -- SJÖGREN SYNDROME -- SYSTEMIC SCLEROSIS -- IDIOPATHIC INFLAMMATORY MYOPATHY -- MIXED CONNECTIVE TISSUE DISEASE -- SERONEGATIVE SPONDYLARTHROPATHIES -- RELAPSING POLYCHONDRITIS -- Chapter 27 The Eosinophilic Lung Diseases -- BIOLOGY OF THE EOSINOPHIL -- SIMPLE PULMONARY EOSINOPHILIA -- CHRONIC EOSINOPHILIC PNEUMONIA -- ACUTE EOSINOPHILIC PNEUMONIA -- CHURG-STRAUSS VASCULITIS -- IDIOPATHIC HYPEREOSINOPHILIC SYNDROME -- ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS -- BRONCHOCENTRIC GRANULOMATOSIS. |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | PARASITIC INFECTIONS -- FUNGAL INFECTIONS -- DRUG REACTIONS -- LUNG DISEASES OCCASIONALLY ASSOCIATED WITH EOSINOPHILS -- CLINICAL APPROACH -- Chapter 28 Systemic Sarcoidosis -- DEFINITION -- EPIDEMIOLOGY -- ETIOLOGY -- PATHOLOGY -- IMMUNOPATHOGENESIS -- CLINICAL MANIFESTATIONS -- ESTABLISHING THE DIAGNOSIS -- ASSESSMENT AND DIAGNOSIS -- TREATMENT -- Chapter 29 Bronchiolar Disease and Bronchiolitis Obliterans- Organizing Pneumonia -- ANATOMY AND DEFINITION -- CLASSIFICATION -- RADIOGRAPHIC FINDINGS -- IMPAIRMENT OF PULMONARY FUNCTION -- SPECIFIC CLINICOPATHOLOGIC FORMS OF DISEASE INVOLVING THE SMALL CONDUCTING AIRWAYS -- BRONCHIOLITIS OBLITERANS-ORGANIZING PNEUMONIA -- Chapter 30 Pulmonary Vasculitis -- ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES -- WEGENER GRANULOMATOSIS -- POLYARTERITIS NODOSA -- MICROSCOPIC POLYANGIITIS -- CHURG-STRAUSS ANGIITIS (ALLERGIC ANGIITIS AND GRANULOMATOSIS) -- BRONCHOCENTRIC GRANULOMATOSIS -- NECROTIZING SARCOID ANGIITIS AND GRANULOMATOSIS -- LYMPHOMATOID GRANULOMATOSIS -- BEHÇET DISEASE -- HUGHES-STOVEN SYNDROME -- TAKAYASU ARTERITIS -- HENOCH-SCHÖNLEIN SYNDROME -- Chapter 31 Alveolar Hemorrhage Syndromes -- CLINICAL MANIFESTATIONS -- HISTOPATHOLOGY -- DIAGNOSIS -- GOODPASTURE SYNDROME -- SMALL-VESSEL VASCULITIS -- WEGENER GRAUNLOMATOSIS -- SYSTEMIC LUPUS ERYTHEMATOSUS -- OTHER CONNECTIVE TISSUE DISORDERS -- DRUG-INDUCED ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS -- MISCELLANEOUS CAUSES OF ALVEOLAR HEMORRHAGE -- Chapter 32 Major Pulmonary Disease Syndromes of Unknown Etiology -- PULMONARY ALVEOLAR PROTEINOSIS -- LANGERHANS CELL HISTIOCYTOSIS -- LYMPHANGIOLEIOMYOMATOSIS -- PULMONARY AMYLOIDOSIS -- Chapter 33 Drug-Induced Pulmonary Disease -- PATTERNS OF RESPONSE -- EFFECTS OF SPECIFIC DRUGS -- Chapter 34 Radiation-Induced Lung Disease -- HISTORICAL PERSPECTIVES -- PRINCIPLES OF RADIATION BIOLOGY. |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | FOLLOW-UP AND PHYSIOLOGIC CHANGES. |
588 ## - SOURCE OF DESCRIPTION NOTE | |
Source of description note | Description based on publisher supplied metadata and other sources. |
590 ## - LOCAL NOTE (RLIN) | |
Local note | Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lungs -- Diseases. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pleura -- Diseases. |
655 #4 - INDEX TERM--GENRE/FORM | |
Genre/form data or focus term | Electronic books. |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Glassroth, Jeffrey L. |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Karlinsky, Joel B. |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
Relationship information | Print version: |
Main entry heading | Crapo, James D. |
Title | Baum's Textbook of Pulmonary Diseases |
Place, publisher, and date of publication | Philadelphia : Lippincott Williams & Wilkins,c2003 |
International Standard Book Number | 9780781737272 |
797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN) | |
Corporate name or jurisdiction name as entry element | ProQuest (Firm) |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3418680">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3418680</a> |
Public note | Click to View |
No items available.